FDA Inspection 1007257 — MedImmune U.K. Limited
The FDA completed an inspection of MedImmune U.K. Limited on Feb 17, 2017 in Liverpool. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 17, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Liverpool (United Kingdom)